In another study, reduced levels of adropin were associated with renal dysfunction in patients with type 2 diabetes mellitus, and adropin was proposed to be used as a biomarker for the early diagnosis of diabetic nephropathy [29]. The gene discussed is ENHO; the disease is type 2 diabetes mellitus.